Abstract
Since the middle of the nineteenth century, physiologists have been aware of an endogenous vasoconstrictor substance. Often referred to as “vasotonin,” the factor was present in the serum of clotted blood. (1948) succeeded in isolating the compound and named it “serotonin.” The chemical structure was soon found to be 5-hydroxytryptamine (5-HT). Simultaneously and independently, Italian scientists were studying a substance found in high concentrations in enterochromaffin cells of the intestinal mucosa that was also eventually found to be 5-HT (Erpsamer and Asero, 1952). The synthetic production of 5-HT (Hamlin and Fischer, 1951) led to an explosion of research into the physiologic function of this compound.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahn H. S. and Makman M. H (1978) Serotonin sensitive adenylate cyclase activity in monkey anterior limbic cortex antagonism by molindone and other antipsychotic drugs Life Sci 23, 507–512.
Allen G. S and Banghart S. B (1979) Cerebral arterial spasm. Part 9. In vitro effects of nifedipine on serotonin-, phenylephrine-, and potassium-induced contractions of canine basilar and femoral arteries Neurosurg. 4, 37–42
Allen G. S., Gross C J., Henderson L. M, and Chou S. N. (1976) Cerebral arterial spasm. Part 4: In vitro effects of temperature, serotonin, analogues, large nonphysiologic concentrations of serotonin and extracellular calcium and magnesium on serotonin-induced contractions of the canine basilar artery. J Neurosurg 44, 585–593.
Allen G. S., Henderson L. M., Chou S N., and French L A. (1974) Cerebral arterial spasm Part 1. In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries J. Neurosurg. 40, 433–441
Apperley E., Feniuk W., Humphrey P. P A, and Levy G. P (1980) Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature, Brit J Plzarmacol. 68, 215–224.
Barbaccia M L., Brunello N., Chuang D. M., and Costa E. (1983) Serotonin-elicited amplification of adenylate cyclase activity in hippocampal membranes from adult rat. J. Neurochem. 40, 1671–1679
Bennett J L. and Aghalanian G. K (1974) D-LSD binding to brain homogenates. possible relationship to serotonin receptors Life Sci. 15, 1935–1944
Bennett Jr, J P and Snyder S H (1975) Stereospecific binding of d-lysergic acid diethylamide (LSD) to brain membranes relationship to serotonin receptors. Brain Res. 94, 523–544
Bennett Jr, J. P. and Snyder S H. (1976) Serotonin and lysergic acid diethylamide binding in rat brain membranes. relationship to postsynaptic serotonin receptors. Mol Pharmacol 12, 373–389
Berry-Kravis E. and Dawson G (1983) Characterization of an adenylate cyclase-linked serotonin (5-HT1) receptor in a neuroblastoma × brain explant hybrid cell line (NCB-20). J. Neurochem 40, 977–985
Biegon A., Rainbow T C., and McEwen B. S (1982) Quantitative autoradiography of serotonin receptors in the rat brain. Brain Res. 242, 197–204.
Bohr D. F, Goulet P. L., and Taquini A C. (1961) Direct tension recording from smooth muscle of resistance vessels from various organs Angiology 12, 478–485
Bradley P. B., Humphrey P. P A., and Williams R H. (1983) Are vascular ′d′ and ′5-HT2′ receptors for 5-hydroxytryptamme the same? Brit j Pharmacol 79, 295P
Cerrito F and Raiteri M. (1979) Serotonin release is modulated by pre-synaptic autoreceptors Eur. J. Pharmacol 57, 427–430.
Cohen M L, Mason N, Wiley K. S, and Fuller R W. (1983) Further evidence that vascular serotonin receptors are of the 5-HT2 type. Biochem. Pharmacol. 32, 567–570
Cohen M. L, Fuller R W., and Wiley K. S. (1981) Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. J Pharmacol. Exp. Ther. 218, 421–425
Colpaert F. C and Janssen P A. J (1983) The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist. Neuropharmacol 22, 993–1000.
Cortes R, Palacios J M., and Pazos A. (1984) Visualisation of multiple serotonin receptors in the rat brain by autoradiography Brit J. Pharmacol 82(suppl), 202P.
Coughlin S. R, Moskowitz M A., and Levine L. (1984) Identification of a serotonin type 2 receptor linked to prostacyclin synthesis in vascular smooth muscle cells. Biochem. Pharmacol. 33, 692–694.
Cox B and Ennis C. (1982) Characterization of 5-hydroxytryptaminergic autoreceptors in the rat hypothalamus. j Pharm. Pharmacol 34,438–441.
Creese I. and Snyder S H (1978) 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus. Eur J. Pharmacol 49, 201–202.
Curro F A., Greenberg S., Verbeuren T J., and Vanhoutte P. M. (1978) Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins J Pharmacol. Exp Ther 207, 936–949
DeClerck F. F. and Herman A. G (1983) Hydroxytryptamine and platelet aggregation Fed Proc. 42, 228–232.
Deshmukh P P., Yamamura H. I, Woods L, and Nelson D. L (1983) Computer-assisted autoradiographic localization of subtypes of serotonin1 receptors in rat brain Brain Res 288, 338–343.
Dompert W. U, Glaser T., and Traber J (1985) 3H-TVXQ7821:Identification of 5-HT1 binding sites as target for a novel putative anxiolytic Naunyn-Schmledeberg’s Arch Pharmacol. 328, 467–470
Edvinsson L and Hardebo J E (1976) Characterization of serotonin receptors in intracranial and extracranial vessels Acta Physiol Scand 97, 523–525.
Edvinsson L., Hardebo J. E., and Owman C (1978) Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man Circ Res. 42, 143–151
Engel G., Gothert M., Muller-Schweinitzer E., Schlicker E., Sistonen L, and Stadler P A (1983) Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS, and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn Schmiedeberg’s Arch Pharmacol. 324, 116–124.
Engel G., Muller-Schweinitzer E, and Palacios J. M (1984) 2-[125Iodo] LSD, a new ligand for the characterisation and localisation of 5HT2 receptors Naunyn Schmiedeberg’s Arch. Pharmacol. 325, 328–336
Enjalbert A., Bourgoin S., Hamon M., Adrien J, and Bockaert J. (1978a) Postsynaptic serotonin-sensitive adenylate cyclase in the central nervous system. Mol Pharmacol 14, 2–10.
Enjalbert A., Hamon M, Bourgoin S, and Bockaert J (1978b) Postsynaptic serotonin-sensitive adenylate cyclase in the central nervous system Mol Pharmacol. 14, 11–23
Ennis C. and Cox B. (1982) Pharmacological evidence for the existence of two distinct serotonin receptors in rat brain. Neuropharmacol. 21, 41–44.
Erpsamer V and Asero B. (1952) Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine Nature (Lond ) 168, 800–801
Farnebo L. O. and Hamberger B. (1974) Regulation of [3H] 5-hy-droxytryptamine release from rat brain slices J Pharm. Pharmacol 26, 642–644.
Feniuk W, Humphrey P. P A, and Watts A D. (1983) Further evidence for the heterogeneity of vascular receptors for 5-HT. Brit j Pharmacol. 79, 296P
Fillion G. (1983) 5-Hydroxytryptamine Receptors in Brain, in Handbook of Psychopharmacology, Vol. 17 (Iversen L. L., Iversen S. D., and Snyder S. H., eds.) pp. 139–166, Plenum, New York.
Fillion G M. B., Rousselle J., Fillion M, Beaudoin D. M, Goiny M R, Deniau J, and Jacob J J (1978) High-affinity binding of [3H]5-Hydroxytryptamine to brain synaptosomal membranes comparison with [3H]lysergic acid diethylamide binding Mol. Pharmacol 14, 50–59
Fillion G., Beaudoin D., Rousselle J. C, Deniau J. M., Fillion M P, Dray F, and Jacob J (1979a) Decrease of [3H]5-HT high-affinity binding and 5-HT adenylate cyclase activation after kainic acid lesion in rat brain striatum. J Neurochem 33, 567–570.
Fillion G, Rousselle J. C., Beaudoin D, Pradelles P., Goiny M., Dray F, and Jacob, J. (1979b) Serotonin sensitive adenylate cyclase in horse brain synaptosomal membranes. Life Sci. 24, 1813–1822
Fillion G, Beaudom D., Rousselle J C., and Jacob J, (1980) [3H]5-HT binding sites and 5-HT-sensitive adenylate cyclase in glial cell membrane fraction. Brain Res. 198, 361–374.
Fillion G., Beaudoin D, Flllion M., Rousselle J. C., Robaut C, and Netter Y (1983) 5-Hydroxytryptamine receptors in neurons and glia. J. Neural Transmission, Suppl 18, 307–317.
Forster C. and Whalley E T. (1982) Analysis of the 5-hydroxytryptamine induced contraction of the human basilar arterial strip compared with the rat aortic strip in vitro. Naunyn Schmiedeberg’s Arch. Pharmaco1 319, 12–17
Friedman R L, Barrett R J, and Sanders-Bush E. (1983) Discriminative cue properties of quipazine mediation by serotonin-2 binding sites Soc. Neurosci Abs 9, 335
Furchgott R F (1978) Pharmacological characterization of receptors its relation to radioligand-binding studies. Fed Proc. 37, 115–120.
Gaddum J. H. and Picarelli Z. P. (1957) Two kinds of tryptamine receptor. Brit J. Pharmacol Chemother 12, 323–328
Geaney D. P., Schachter M., Elliot J. M, and Grahame-Smith D. G (1984) Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes. Eur J Pharmacol 97, 87–93.
Glennon R. A, Young R., and Rosecrans J. A. (1983) Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Eur. J. Pharmacol. 91, 189–196.
Gothert M. (1980) Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurons of the rat brain cortex. Naunyn-Schmiedeberg’s Arch. Pharmacol 314, 223–230.
Gozlan H., El Mestikawy S., Pichat L, Glowmski J, and Hamon M. (1983) Identification of presynaptic serotonin autoreceptors using a new ligand. 3H-PAT. Nature (Lond.) 305, 140–142.
Haigler H. J and Aghajanian G K (1977) Serotonin receptors in the brain. Fed. Proc 36, 2159–2164.
Hall M., El Mestikawy S., Emerit M, Pichat L, Hamon M, Gozlan H (1985) 3H-8-Hydroxy-2-(di-n-propylamino) tetralin binding to pre-and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain J Neurochem 44, 1686–1696.
Hamlin K. E. and Fischer F E (1951) The synthesis of 5-hydroxytryptamine. J Am Chem Soc 73, 5007–5008
Hartig P R., Kadan M J, Evans J. J., and Krohn A. M. (1983) 125I-LSD a high-sensitivity ligand for serotonin receptors Eur J Pharmacol 89, 321–322.
Humphrey P P. A, Feniuk W., and Watts A. D (1982) Ketanserin—a novel antihypertensive drug? J Pharm Pharmacol. 34, 541.
Jacobs B. L. (1976) An animal behavioral model for studying central serotonergic synapses Life Sci 19, 777–786.
Kalkman H. O., Batink H. D, ThoolenM. J. M. C, Timmermans P. B M W. M, and Van Zwieten P. A (1983a) Correlation between the affinity for [3H]mianserin-labeled receptors in brain and antagonism of the serotonin pressor response in pithed rats Biochem Pharmacol 32, 2111–2113
Kalkman H. O., Boddeke H. W. G. M, Doods H N., Timmermans P. B M W M, and Van Zwieten P A. (1983b) Hypotensive activity of serotonin receptor agonists in rats is related to their affinity for 5-HT1 receptors Eur J Pharmacol. 91, 155–156.
Kendall D. A. and Nahorski S R. (1983) Temperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [3H]spiperone binding to rat cortical membranes regulation by guanine nucleotide and antidepressant treatment J Pharmacol Exp Ther 227, 429–434.
Kendall D. A and Nahorski S R. (1984) Suppression of 5-HT2 receptor mediated inositol phospholipid breakdown in brain by chronic antidepressant treatment Brit J Pharmacol. 82(suppl), 206P
Leysen J E. (1981) Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding studies in vitro. J. Physiol (Paris) 77, 351–362.
Leysen J. E and Tollenaere J. P (1982) Biochemical models for serotonin receptors. Ann. Rev Med Chem 17, 1–10.
Leysen J. E., Niemegeers C. J. E, Tollenaere J P., and Laduron P. M. (1978) Serotonergic component of neuroleptic receptors. Nature (Lond ) 272, 163–166
Leysen J. E., Niemegers C J E., Van Nueten J M, and Laduron P M (1982) 3H-Ketanserin (R 41 468), a selective 3H-ligand for receptor binding sites. Mol Pharmacol 21, 301–314.
Limbird L. E. (1981) Activation and attenuation of adenylate cyclase. Biochem J 195, 1–13.
Lovell R. A and Freedman D. X. (1976) Stereospecific receptor sites for D-lysergic acid diethylamide in rat brain: effects of neurotransmitters, amine antagonists, and other psychotropic drugs. Mol Pharmacol 12, 620–630.
Lucki I, Nobler M S., and Frazer A. (1984) Different actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J. Pharmacol Exp. Ther 228, 133–139
Maguire M E, Ross E. M, and Gilman A G (1977) β-Adrenergic receptor: ligand binding properties and the interaction with adenylyl cyclase. Adv. Cyclic Nucleotide Res 8, 1–83
Maayani S and Stollak J (1983) 5-HT receptors in isolated rabbit aorta Characterization by spiroperidol and other butyrophenones Fed. Proc. 42, 1150
Mallat M. and Hamon M (1982) Ca2+-guanine nucleotide interactions in brain membranes. I Modulation of central 5-hydroxytryptamine receptors in the rat. J Neurochem 8, 151–161
Marcinkiewicz M., Verge D., Gozlan H., Pichat L., and Hamon M (1984) Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain. Brain Res 291, 159–363.
Martin L L. and Sanders-Bush E (1982a) The serotonin autoreceptor. antagonism by quipazine. Neuropharmacol. 21, 445–450.
Martin L L and Sanders-Bush E (1982b) Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn-Schmiedeberg’s Arch. Pharmacol. 321, 165–170.
Middlemiss D N. and Fozard J. R. (1983) 8-hydroxy-2(DI-n-Propyl-amino)-tetralin discriminates between sybtypes of the 5-HT1 recognition site. Eur J. Pharmacol 90, 151–153.
Muller-Schweinitzer E (1980) The mechanism of ergometrine-induced coronary arterial spasm In vitro studies on canine arteries J Cardiovas Pharmacol. 2, 645–655.
Nelson D. L, Herbet A, Bourgoin S, Glowinski J., and Hamon M (1978) Characteristics of central 5-HT receptors and their adaptive changes followmg intracerebral 5,7-dihydroxy-tryptamine administration in the rat Mol Pharmacol. 14, 983–995.
Nelson D L, Herbet A., Enjalbert A., Bockaert J., and Hamon M. (1980a) Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat. I. Biochem. Pharmacol 29, 2445–2453.
Nelson D. L, Herbet A., Adrien J., Bockaert J., and Hamon M. (1980b) Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sies in the CNS of the rat II Biochem Pharmacol 29, 2455–2463.
Norman A. B., Battaglia G, Morrow A L., and Creese I. (1985) [su3H-WB4101 labels S1 serotonin receptors in rat cerebral cortex. Eur J Pharmacol. 106: 461–462
Ortmann R., Brschoff S., Radeke E, Buech O., and Delini-Stula A. (1982) Correlations between different measures of antiserotonin activity of drugs. Naunyn-Schmiedeberg’s Arch Pharmacol 321, 265–270.
Palacios J. M., Niehoff D. L., and Kuhar M. J. (1981) [3H]Spiperone binding sites in brain autoradiographic localization of multiple receptors. Brain Res. 213, 277–289.
Palacios J. M., Probst A, and Cortes R. (1983) The distribution of serotonin receptors in the human brain. high density of [3H]LSD binding sites in the raphe nuclei of the brainstem Brain Res. 274, 150–155.
Pazos A., Engel G., and Palacios J. (1985) Beta-adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain. Brain Res 343, 403–408.
Pazos A., Hoyer D., and Palacios J. (1985) The binding of serotonergic ligands to the porcine choroid plexus Characterization of a new type of serotorun recognition site. Eur J. Pharmacol. 106, 539–546.
Pedigo N W., Yamamura H I, and Nelson D. L. (1981) Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain J. Neurochem 36, 220–226.
Peroutka S. J. (1984) Vascular serotonin receptors correlation with 5-HT1 and 5-HT2 binding sites. Biochem Pharmacol 33, 2349–2353.
Peroutka S. J. (1985) Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brain. Brain Res. 344, 167–171.
Peroutka S. J. and Kuhar M. J, (1984) Autoradiographic localization of 5-HT1 receptors to human and canine basilar arteries Brain Res. 310, 193–196.
Peroutka S J. and Snyder S H (1979) Multiple serotonin receptors Differential binding of 3H-serotonin, 3H-lysergic acid diethylamide, and 3H-spiroperidol Mol Pharmacol 16, 687–699
Peroutka S. J. and Snyder S H. (1980a) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210, 88–90.
Peroutka S. J. and Snyder S. H. (1980b) Regulation of serotonin2 (5-HT2) receptors labeled with 3H-spiroperidol by chronic treatment with the antidepressant amitriptyline. J. Pharmacol Exp. Ther 15, 582–587.
Peroutka S. J. and Snyder S H. (1981) Two distinct serotonin receptors: Regional variations in receptor binding in mammalian brain. Brain Res. 208, 339–347
Peroutka S. J. and Snyder S.H. (1983) Multiple serotonin receptors and their physiological significance Fed Proc 42, 213–217.
Peroutka S J., Lebovitz R. M., and Snyder S. H. (1979) Serotonin receptor binding affected differentially by guanine nucleotides. Mol Pharmacol. 16, 700–708
Peroutka S J, Lebovitz R. M, and Snyder S H. (1981) Two distinct central serotonin receptors with different physiological functions. Science 212, 827–829.
Peroutka S. J,, Noguchi M, Tolner D. J., and Allen G S (1983) Serotonin induced contraction of canine basilar artery. mediation by 5-HT1 receptors. Brain Res. 259, 327–330.
Pletscher A and Affolter H (1983) The 5-hydroxytryptamine receptor of blood platelets. J Neural Transmission 57, 233–242.
Quik M, Iversen L. L., Lardner A, and Mackay A V P (1978) Use of ADTN to defme specific 3H-spiperone binding to receptors in brain Nature (Lond ) 274, 513–514.
Rapport M. M., Green A A., and Page I. H (1948) Serum vasoconstrictor (serotonin) IV. Isolation and characterization. J Biol Chem 176, 1243–1251.
Roberts M. H T and Straughan D. W (1967) Excitation and depression of cortical neurones by 5-hydroxytryptamine. J Physiol (Lond.) 193, 269–294.
Rodbell M (1980) The role of hormone receptors and GTP regulatory proteins in membrane transduction Nuture (Lond.) 284, 17–21
Rogawski M. A. and Aghajanian G. K. (1981) Serotonin autoreceptors on dorsal raphe neurons. structure-activity relationships of tryptamine analogs J Neurosci 1, 1148–1154
Sastry B. S R. and Phlllis J W (1977) Metergoline as a selective 5-hydroxytryptamine antagonist in the cerebral cortex Can J Physiol Pharmacol. 55, 130–133
Schmauss C., Hammond D. L., Ochi J. W., and Yaksh T L (1983) Pharmacological antagonism of the antinociceptive effects of serotonin in the rat spinal cord. Eur. J Pharmacol. 90, 349–357.
Schnellmann R G., Waters S J, and Nelson D L. (1984) [3H]5-hydroxytryptamine binding sites species and tissue variation J Neurochem 42, 65–70.
Schotte A., Maloteaux J. M, and Laduron P M (1983) Characterization and regional distribution of serotonin S2-receptors in human brain Brain Res 276, 231–235
Shenker A, Maayani S, Weinstein H, and Green J. P. (1983) Characterization of a serotonin receptor coupled to adenylate cyclase in adult guinea pig hippocampus Soc. Neurosci Abs 9, 1152.
Sills M. A., Wolfe B. B., and Frazer A (1984b) Determination of selective and nonselective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231, 480–487.
Slater P. and Pate1 S. (1983) Autoradiographic distribution of serotonin2 receptors in rat brain Eur J. Pharmacol. 92, 297–298.
Snyder S. H (1983) Molecular Aspects of Neurotransmitter Receptors. An Overview, in Handbook of Psychopharmacology, Vol. 17, (Iversen L. L, Iversen S. D., and Snyder S. H., eds.), pp. 1–12, Plenum, New York.
Snyder S. H. (1984) Drug and neurotransmitter receptors in the brain. Science 224, 22–31
Titeler M., Battaglia G, and Shannon M (1984) Guanine nucleotides modulate cortical S2 serotonin receptors Soc. Neurosci Abs 9, 334
Toda N and Fujita Y. (1973) Responsiveness of isolated cerebral and peripheral arteries to serotonin, norepinephrine, and transmural electrical stimulation. Circ Res 33, 98–104
Twarog B. M. and Page I. H (1953) Serotonin content of some mammalian tissues and urine and a method for its determmation Am J Psychiat. 175, 157–161.
Van Nueten J M, Leysen J. E., Vanhoutte P M., and Janssen P A (1982) Serotonergic responses in vascular and nonvascular tissues. Arch. Int Pharmacodyn 256, 331–334.
Von Hungen K, Roberts S., and Hill D. F (1974) Developmental and regional variations in neurotransmitter-sensitive adenylate cyclase systems in cell-free preparations from rat brain J Neurochem 22, 811–819
Von Hungen K, Roberts S, and Hill D. F (1975) Serotonin-sensitive adenylate cyclase activity in immature rat brain. Brain Res 84, 257–267
Wrigglesworth S. J. (1983) Heterogeneity of 5-hydroxytryptamine receptors in the rat uterus and stomach strip Brit.J Pharmacol 80,691–697
Yamamura H. I., Enna S. J., and Kuhar M J, (eds.) (1978) Neurotransmitter Receptor Binding. Raven Press, New York
Yap C. Y and Taylor D. A. (1983) Involvement of 5-HT2 receptors in the wet-dog shake behavior induced by 5-hydroxytryptophan in the rat Neuropharmacol 22, 801–804.
Young W. S., III and Kuhar M. J, (1980) Serotonin receptor localization in rat brain by light microscopic autoradiography Eur J Pharmacol 62, 237–239
Editor information
Rights and permissions
Copyright information
© 1986 The Humana Press Inc.
About this protocol
Cite this protocol
Peroutka, S.J. (1986). Serotonin Receptors. In: Boulton, A.A., Baker, G.B., Hrdina, P.D. (eds) Receptor Binding. Neuromethods, vol 4. Humana Press. https://doi.org/10.1385/0-89603-078-4:93
Download citation
DOI: https://doi.org/10.1385/0-89603-078-4:93
Publisher Name: Humana Press
Print ISBN: 978-0-89603-078-7
Online ISBN: 978-1-59259-609-6
eBook Packages: Springer Protocols